Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Optimark (Gadoversetamide) in Pediatric Patients

NCT01092754 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Pathological Processes

Interventions

PROCEDURE: MRI
PROCEDURE: MRI
DRUG: Gadoversetamide

Sponsor

Guerbet